Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06458595
What this trial is testing

Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 44
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Not applicableUnknownNCT04601675
What this trial is testing

Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

Who this might be right for
Macular Edema
He Eye Hospital 100
Not applicableUnknownNCT02960828
What this trial is testing

"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

Who this might be right for
Age-Related Macular DegenerationRetinal Drusen
Seoul National University Bundang Hospital 21
Not applicableLooking for participantsNCT07255859
What this trial is testing

AVIGA3 (Cohort 2.0)

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Not applicableStudy completedNCT05287269
What this trial is testing

Ocular Coherence Tomography During Cataract Assessment

Who this might be right for
Cataract SenileMacula HoleEpiretinal Membrane+2 more
Brighton and Sussex University Hospitals NHS Trust 626
Post-approval studies (Phase 4)Study completedNCT00135837
What this trial is testing

Photodynamic Therapy in Occult-Only Lesions (POOL)

Who this might be right for
Age-Related Macular Degeneration
Novartis 202
Post-approval studies (Phase 4)Study completedNCT00469781
What this trial is testing

Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

Who this might be right for
Cystoid Macular Edema,Retinal Thickening
Center For Excellence In Eye Care 95
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Early research (Phase 1)Study completedNCT00018070
What this trial is testing

Identification and Treatment of Feeder Vessels in Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00001615
What this trial is testing

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 180
Testing effectiveness (Phase 2)Study completedNCT02181517
What this trial is testing

Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Large-scale testing (Phase 3)Looking for participantsNCT07614776
What this trial is testing

Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationnAMD
Amgen 304
Early research (Phase 1)Study completedNCT02332941
What this trial is testing

Treatment -Resistant Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Washington University School of Medicine 5
Large-scale testing (Phase 3)Study completedNCT00000145
What this trial is testing

Age-Related Eye Disease Study (AREDS)

Who this might be right for
Macular DegenerationCataractLens Opacities
National Eye Institute (NEI) 4,757
Not applicableUnknownNCT05342857
What this trial is testing

Maximum Treatment Interval With Aflibercept T&E

Who this might be right for
Neovascular Age-related Macular Degeneration
Shin Kong Wu Ho-Su Memorial Hospital 100
Not applicableStudy completedNCT00647439
What this trial is testing

Genetics and Markers of Degenerative and Inflammatory Eye Diseases

Who this might be right for
Diabetic RetinopathyAge-Related Macular Degeneration (AMD)Uveitis
National Eye Institute (NEI) 609
Testing effectiveness (Phase 2)Looking for participantsNCT07185256
What this trial is testing

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

Who this might be right for
ARBBVMDAutosomal-Dominant Bestrophinopathy+1 more
Opus Genetics, Inc 10
Not applicableStudy completedNCT06124677
What this trial is testing

Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments

Who this might be right for
Neovascular Age-related Macular Degeneration
Rigshospitalet, Denmark 46
Next Page